Nuwellis, Inc. (NUWE) Stock Price & Analysis

Nuwellis, Inc. (NUWE) rose 6.29% to USD 0.78 as of September 8, 2026 at 10:53 UTC, according to Nexqual real-time market data.

NUWE last closed at USD 0.78; the session ranged USD 0.74–0.78 on volume of 223,486 shares. Market capitalization is —, with a 52-week range of USD 0.71–183.05 (NCM). Source: Nexqual, September 8, 2026 at 10:53 UTC.

Key Statistics (as of September 8, 2026 at 10:53 UTC)

Technical Analysis (NUWE)

Nexqual's technical model rates NUWE "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 10:53 UTC.

From Nuwellis, Inc.'s Latest SEC 10-K Filing (filed 2026-03-11)

Key Strengths & Strategy (as disclosed to the SEC)

• Food and Drug Administration ("FDA") to support its use in the applications identified immediately above.   The Company believes the total U.S. critical care failure market is approximately $900 million. 6 5 In 2025, the Company derived approximately 32% of its revenue from the treatment of critical care patients.   56  https://idataresearch.com/new-study-shows-approximately-340000-cabg-procedures-per-year-in-the-united-states/. 57  Kruger A et al.
• The company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow® and the Aquadex SmartFlow® systems (collectively the "Aquadex System").
• With our FDA 510(k) clearance for use in pediatric patients weighing 20kg or more, we have expanded our commercialization efforts to treatments for pediatric patients.   Critical Care : We have launched a marketing campaign focused on the benefits of the Aquadex System in treating patients suffering from fluid overload following cardiac surgery procedures, such as CABG surgery, valve repairs and replacements procedures, VAD implants and other cardiac surgical procedures.
• In February 2020, the Company received FDA 510(k) clearance for the Aquadex System to include pediatric patients who weigh 20kg or more.

Partnerships

• We purchased parts and components for the Aquadex System from third-party manufacturers and suppliers.   19 Table of Contents On May 12, 2025, the Company announced it had finalized an agreement with KDI Precision Manufacturing to support the next phase of Nuwellis' growth.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:53 UTC. This page is informational and not investment advice.